0000908662-18-000228.txt : 20181119 0000908662-18-000228.hdr.sgml : 20181119 20181119110024 ACCESSION NUMBER: 0000908662-18-000228 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20181119 DATE AS OF CHANGE: 20181119 EFFECTIVENESS DATE: 20181119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brooklyn Immunotherapeutics Investors LP CENTRAL INDEX KEY: 0001758682 IRS NUMBER: 832113725 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326067 FILM NUMBER: 181191581 BUSINESS ADDRESS: STREET 1: 109 N. POST OAK LANE, SUITE 530 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 713-337-9150 MAIL ADDRESS: STREET 1: 109 N. POST OAK LANE, SUITE 530 CITY: HOUSTON STATE: TX ZIP: 77024 D 1 primary_doc.xml X0708 D LIVE 0001758682 Brooklyn Immunotherapeutics Investors LP 109 N. POST OAK LANE, SUITE 530 HOUSTON TX TEXAS 77024 713-337-9150 DELAWARE None None Limited Partnership true 2018 N/A Brooklyn Immunotherapeutics Investors GP LLC 109 N. Post Oak Lane, Suite 530 Houston TX TEXAS 77024 Director General Partner of Issuer Charles R. Cherington 109 N. Post Oak Lane, Suite 530 Houston TX TEXAS 77024 Director Manager of General Partner of Issuer George P. Denny III 109 N. Post Oak Lane, Suite 530 Houston TX TEXAS 77024 Director Manager of General Partner of Issuer Investing Decline to Disclose 06b 3C 3C.1 false 2018-11-06 false true false 0 21247005 21180153 66852 false 85 0 0 0 true false Brooklyn Immunotherapeutics Investors LP /s/ Charles R. Cherington Charles R. Cherington Manager of General Partner of Issuer 2018-11-07